+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 18Years +
All Genders
ID04875819

Evaluating Safety and Immune Response to Meningococcal and Pneumococcal Vaccines in Adults Living with HIV on Antiretroviral Therapy

Led by Thomas Benfield · Updated on 2021-05-06

55

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and immune response of meningococcal and pneumococcal vaccines in adults living with HIV who are receiving antiretroviral treatment. This trial is a single-center, randomized controlled study designed to compare two different vaccination regimens to better understand their effects on this population. The study is investigator-initiated and focuses on long-term immunogenicity and safety outcomes. Participants are randomly assigned to receive either a two-dose regimen of Menveo a conjugate vaccine against meningococcal serogroups ACWY combined with Bexsero a vaccine against meningococcal serogroup B at day 0 and day 60, or a prime-boost regimen of Prevenar13 a 13-valent pneumococcal conjugate vaccine and Pneumovax23 a 23-valent pneumococcal polysaccharide vaccine given at day 0 and day 60. A crossover between groups occurs at day 90. All participants follow the same follow-up schedule including collection of plasma, pharyngeal swabs, and recording of any adverse events. Throughout the study, blood samples are taken at 30 days post-vaccination and yearly for five years to measure immune responses. Researchers will monitor immediate, short-term, and long-term side effects after vaccination, as well as bacterial carriage rates at baseline and day 30. The total duration of participant involvement includes the initial vaccinations, crossover, and follow-up visits to assess vaccine safety and effectiveness over time.

CONDITIONS

Brief Title

Safety and Immunogenicity Following Meningococcal and Pneumococcal Immunization Among Adult People Living With HIV

Research Team

M

Michaela Tinggaard, M.D.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here